The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia

Journal of Psychopharmacology

Volumn 24, Issue 7, 2010, Pages 1055-1067

  Abou El Magd, R M ^a   Park, H K ^a   Kawazoe, T ^a   Iwana, S ^a   Ono, K ^a   Chung, S P ^a   Miyano, M ^b   Yorita, K ^a   Sakai, T ^a   Fukui, K ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Shouseikai Nishide Hospital   (Japan)

Author keywords

D amino acid oxidase; D serine; NMDA receptors; Risperidone

Indexed keywords

DEXTRO AMINO ACID OXIDASE; RISPERIDONE;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL VIABILITY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA; SWINE;

ANIMALS; ANTIPSYCHOTIC AGENTS; APOENZYMES; APOPROTEINS; BLOTTING, WESTERN; CATALYSIS; CELL SURVIVAL; CULTURE MEDIA; D-AMINO-ACID OXIDASE; ENZYME INHIBITORS; HOLOENZYMES; HUMANS; KINETICS; LLC-PK1 CELLS; MICE; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; RECOMBINANT PROTEINS; RISPERIDONE; SCHIZOPHRENIA; SERINE; SWINE;

EID: 77953755583     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109102644     Document Type: Article

References (73)

1. Aravagiri, M., Marder, SR (2002) Brain, plasma and tissue pharmacokinetics of risperidone and 9-hydroxyrisperidone after separate oral administration to rats. Psychopharmacology (Berl) 159: 424-431.
2. Baldessarini, RJ, Centorrino, F., Flood, JG, Volpicelli, SA, Huston-Lyons, D., Cohen, BM (1993) Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology 9: 117-124.
3. Biber, J., Brown, CD, Murer, H. (1983) Sodium-dependent transport of phosphate in LLC-PKI cells. Biochim Biophys Acta 735: 325-330.
4. Carman, J., Peuskens, J., Vangeneugden, A. (1995) Risperidone in the treatment of negative symptoms of schizophrenia: a meta-analysis. Int Clin Psychopharmacol 10: 207-213.
5. Chumakov, I., Blumenfeld, M., Guerassimenko, O., Cavarec, L., Palicio, M., Abderrahim, H., et al. (2002) Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A 99: 13365-13367.
6. Contreras, PC (1990) D-serine antagonized phencyclidine- and MK-801-induced stereotyped behavior and ataxia. Neuropharmacology 29: 291-293.
7. Cunningham, TJ, Maciejewski, J., Yao, L. (2006) Inhibition of secreted phospholipase A2 by neuron survival and anti-inflammatory peptide CHEC-9. J Neuroinflammation 3: 25.
8. Davidson, M., Emsley, R., Kramer, M., Ford, L., Pan, G., Lim, P., et al. (2007) Efficacy, safety and early response of paliperidone extendedrelease tablets (paliperidone ER). Results of a 6-week, randomized, placebo-controlled study. Schizophr Res 93: 117-130.
9. DeVane, CL, Markowitz, JS (2000) Drugs as substrates of metabolic enzymes: antipsychotics. In: Levy, RH, Thummel, KE, Trager, WF, Hansten, PD, Eichelbaum, M, (eds). Metabolic Drug Interactions. Philadelphia, PA: Lippincott-Raven Press, pp. 245-258.
10. Dixon, M., Webb, EC, Thorne, CJR, Tipton, KF (1964) Enzymes. London: Lomgman, pp. 343-345.
11. Fang, J., Borurin, M., Baker, GB (1999) Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4. Naunyn Schmiedebergs Arch Pharmacol 359: 147-151.
12. Fenton, WS, Blyler, CR, Heinssen, RK (1997) Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 23: 637-651.
13. Fishman, WH (1989) On the importance of being (stereo) specific. Clin Chim Acta 186: 129-132.
14. Fukui, K., Miyake, Y. (1992) Molecular cloning and chromosomal localization of a human gene encoding D-amino acid oxidase. J Biol Chem 267: 18631-18638.
15. Fukui, K., Momoi, K., Watanabe, F., Miyake, Y. (1988) In vivo and in vitro expression of porcine D-amino acid oxidase: In vitro system for the synthesis of a functional enzyme. Biochemistry 27: 6693-6697.
16. Fukui, K., Watanabe, F., Shibata, T., Miyake, Y. (1987) Molecular cloning and sequence analysis of cDNAs encoding porcine kidney D-amino acid oxidase. Biochemistry 26: 3612-3618.
17. Ganote, CE, Peterson, DR, Carone, FA (1974) The nature of D-serine induced nephrotoxicity. Am J Pathol 77: 269-282.
18. Gilbert, SF, Migeon, BR (1975) D-valine as a selective agent for normal human and rodent epithelial cells in culture. Cell 5: 11-17.
19. Goff, DC, Tsai, G., Levitt, J., Hayden, DL, McCarley, R., Coyle, JT (1999) A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiat 56: 21-27.
20. Gstraunthaler, GJ (1988) Epithelial cells in tissue culture. Renal Physiol Biochem 11: 1-42.
21. Gstraunthaler, G., Pfaller, W., Kotanko, P. (1985) Biochemical characterization of renal epithelial cell cultures (LLC-PK1 and MDCK). Am J Physiol 248 (4 pt 2). F536 - F544.
22. Hashimoto, K., Fukushimo, T., Shinizu, E., Komatsu, N., Watanabe, H., Shinoda, N., et al. (2003) Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry 60: 572-576.
23. Hashimoto, A., Nishikawa, T., Hayashi, T., Fujii, N., Harada, K., Oka, T., et al. (1992) The presence of free D-serine in rat brain. FEBS Lett 296: 33-36.
24. Hashimoto, A., Nishikawa, T., Oka, T., Takahashi, K. (1993) Endogenous D-serine in rat brain: N-methyl-D-aspartate receptor-related distribution and aging. J Neurochem 60: 783-786.
25. Hashimoto, A., Oka, T., Nishikawa, T. (1995) Extracellular concentration of endogenous free D-serine in the rat brain as revealed by in vivo microdialysis. Neuroscience 66: 635-643.
26. Hashimoto, A., Oka, T. (1997) Free D-aspartate and D-serine in the mammalian brain and periphery. Prog Neurobiol 52: 325-353.
27. Heresco-Levy, U., Ermilov, M., Lichtenberg, P., Bar, G., Javitt, DC (2004) High dose glycine added to olanzapine and risperidone for the treatment of schizophrenia. Biol Psychiatry 55: 165-171.
28. Heresco-Levy, U., Javitt, DC, Ermilov, M., Mordel, C., Silipo, G., Lichtenstein, M. (1999) Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch Gen Psychiatry 56: 29-36.
29. Heresco-Levy, U., Javitt, DC, Ebstein, R., Vass, A., Lichtenberg, P., Bar, G., et al. (2005) D-Serine Efficacy as Add-on Pharmacotherapy to Risperidone and Olanzapine for Treatment-Refractory Schizophrenia. Biol Psychiatry 57: 577-585.
30. Heykants, J., Huang, ML, Mannens, G., Meuldermans, W., Snoeck, E., Van Beijsterveldt, L., et al. (1994) The pharmacokinetics of risperidone in humans: a summary. J Clin Psychiatry 55: 13-17.
31. Huang, CL (1967) Isolation and identification of urinary chlorpromazine metabolites in man. Int J Neuropharmacol 6: 1-13.
32. Hull, RN, Cherry, WR, Weaver, GW (1976) The origin and characteristics of a pig kidney cell strain, LLC-PK1. In Vitro 12: 670-677.
33. Iwana, S., Kawazoe, T., Park, HK, Tsuchiya, K., Ono, K., Yorita, K., et al. (2008) Chlorpromazine oligomer is a potentially active substance that inhibits human D-amino acid oxidase, product of a susceptibility gene for schizophrenia. J Enzyme Inhib Med Chem 23: 901-911.
34. Kawazoe, T., Tsuge, H., Pilone, MS, Fukui, K. (2006) Crystal structure of human D-amino acid oxidase: Context-dependent variability of the backbone conformation of the VAAGL hydrophobic stretch located at the si-face of the flavin ring. Protein Sci 15: 2708-2717.
35. Marder, SR, Meibach, RC (1994) Risperidone in the treatment of schizophrenia. Am J Psychiatry 151: 825-835.
36. Massey, V., Curti, B. (1966) A new method of preparation of D-amino acid oxidase apoprotein and a conformational change after its combination with flavin adenine dinucleotide. J Biol Chem 241: 3417-3423.
37. Misfeldt, DS, Sanders, MJ (1981) Transepithelial transport in cell culture: D-glucose transport by a pig kidney cell line (LLCPKI). J Membr Biol 59: 13-18.
38. Möller, HJ (1999) Atypical neuroleptics: a new approach in the treatment of negative symptoms. Eur Arch Psychiatry Clin Neurosci 249 (Suppl 4). 99-107.
39. Möller, HJ (2003) Management of the negative symptoms of schizophrenia: new treatment options. CNS Drugs 17: 793-823.
40. Momoi, K., Fukui, K., Watanabe, F., Miyake, Y. (1988) Molecular cloning and sequence analysis of cDNA encoding human kidney D-amino acid oxidase. FEBS Lett 238: 180-184.
41. Mothet, JP, Parent, AT, Wolosker, H., Brady Jr., RO, Linden, DJ, Ferris, CD, et al. (2000) D-Serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A 97: 4926-4931.
42. Nasrallah, HA, Mulvihill, T. (2001) Iatrogenic disorders associated with conventional vs. atypical antipsychotics. Ann Clin Psychiatry 13: 215-227.
43. Ohama, H., Sugiura, N., Tanaka, F., Yagi, K. (1977) Effect of alcohols on the structure and function of D-amino-acid oxidase. Biochemistry 16: 126-131. (Pubitemid 8030076)
44. Park, HK, Shishido, Y., Ichise-Shishido, S., Kawazoe, T., Ono, K., Iwana, S., et al. (2006) Potential role for astroglial D-amino acid oxidase in extracellular D-serine metabolism and cytotoxicity. J Biochem 139: 295-304.
45. Perantoni, A., Berman, JJ (1979) Properties of Wilms tumor line (TuWi) and pig kidney line (LLC-PKI) typical of normal kidney tubular epithelium. In Vitro 15: 446-454.
46. Pfaller, W., Gstraunthaler, G., Loidl, P. (1990) Morphology of the Differentiation and Maturation of LLC-PK1Epithelia. J Cell Physiol 142: 247-254.
47. Pilone, MS (2000) D-Amino acid oxidase: new findings. Cell Mol Life Sci 57: 1732-1747.
48. Prior, TI, Baker, GB (2003) Interactions between the cytochrome P450 system and the second-generation antipsychotics. J Psychiatry Neurosci 28: 99-112.
49. Rabito, CA (1981) Localization of the Na+-sugar cotransport system in a kidney epithelial cell line (LLC-PKI). Biochim Biophys Acta 649: 286-296.
50. Rabito, CA (1983) Phosphate uptake by a kidney cell line (LLC-PK1). Am J Physiol 245: F22 - F31.
51. Rabito, CA, Ausiello, DA (1980) Na+-dependent sugar transport in a cultured epithelial cell line from pig kidney. J Membr Biol 54: 31-38.
52. Rabito, CA, Karish, MV (1982) Polarized amino acid transport by an epithelial cell of renal origin (LLC-PK1). the basolateral systems. J Biol Chem 257: 6802-6808.
53. Rabito, CA, Karish, MV (1983) Polarized amino acid transport by an epithelial cell line of renal origin (LLC-PK1). the apical systems. J Biol Chem 258: 2543-2547.
54. Rabito, CA, Kreisberg, JI, Wight, D. (1984) Alkaline phosphatase and -3-glutamyltranspeptidase as polarization markers during the organization of LLC- PK1 cells into an epithelial membrane. J Biol Chem 259: 574-582.
55. Salzer, JL, Lovejoy, L., Liner, MC, Rosen, C. (1998) Ran-2, a glial lineage marker, is a GPI-anchored form of ceruloplasmin. J Neurosci Res 54: 147-157.
56. Schell, MJ, Molliver, ME, Snyder, SH (1995) D-Serine an endogenous synaptic modulator: localization to astrocytes and glutamatestimulated release. Proc Natl Acad Sci U S A 92: 3948-3952.
57. Schotte, A., Janssen, PF, Gommeren, W., Luyten, WH, Van Gompel, P., Lesage, AS, et al. (1996) Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berlin) 124: 57-73.
58. Schotte, A., Janssen, PF, Megens, AA, Leysen, JE (1993) Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Res 631: 191-202.
59. Scordo, MG, Spina, E., Facciola, G., Avenoso, A., Johannsson, I., Dahl, ML (1999) Cytochcorome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone. Psychopharmacology (Berl) 147: 300-305.
60. Seeman, P. (2005) An update of fast-off dopamine D2 atypical antipsychotics. Am J Psychiatry 162: 1984-1985.
61. Segel, IH (1993) Enzyme Kinetics: Behavior and analysis of rapid equilibrium and steady-state enzyme system. California: John Wiley & Sons, Inc. pp. 189-192.
62. Sepúlveda, FV, Burton, KA, Pearson, JD (1982) The development of gamma- glutamyltransferase in a pig renal-epithelial-cell line in vitro relationship to amino acid transport. Biochem J 208: 509-512.
63. Sepúlveda, FV, Pearson, JD (1982) Characterization of neutral amino acid uptake by cultured epithelial cells from pig kidney. J Cell Physiol 112: 182-188.
64. Snyder, SH (2002) Forty years of neurotransmitters: A personal account. Arch Gen Psychiatry 59: 983-994.
65. Tanii, Y., Nishikawa, T., Hashimoto, A., Takahashi, K. (1994) Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat. J Pharmacol Exp Ther 269: 1040-1048.
66. Tomar, RS, Joseph, TJ, Murthy, AS, Yadav, DV, Subbaiah, G., Krishna Reddy, KV (2004) Identification and characterization of major degradation products of risperidone in bulk drug and pharmaceutical dosage forms. J Pharm Biomed Anal 36: 231-235.
67. Tsai, G., Yang, P., Chung, L-C., Lange, N., Coyle, JT (1998) D-serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 44: 1081-1089.
68. Tsai, GE, Yang, P., Chung, LC, Tsai, IC, Tsai, CW, Coyle, JT (1999) D-serine added to clozapine for the treatment of schizophrenia. Am J Psychiatry 156: 1822-1825.
69. Urai, Y., Jinnouchi, O., Kwak, KT, Suzue, A., Nagahiro, S., Fukui, K. (2002) Gene expression of D-amino acid oxidase in cultured rat astrocytcs: Regional and cell type specific expression. Neurosci Lett 324: 101-104.
70. Van Beijsterveldt, LE, Geerts, RJ, Leysen, JE, Megens, AA, Van den Eynde, HM, Meuldermans, WE, et al. (1994) Regional brain distribution of risperidone and its active metabolite 9-hydroxyrisperidone in the rat. Psychopharmacology 114: 53-62.
71. Yagi, K., Nagatsu, T., Ozawa, T. (1956) Inhibitory action of chlorpromazine on the oxidation of D-amino-acid in the diencephalon part of the brain. Nature 177: 891-892.
72. Yagi, K., Ozawa, T., Nagatsu, T. (1960) Mechanism of inhibition of D-amino acid oxidase. IV. Inhibitory action of chlorpromazine. Biochim Biophys Acta 43: 310-317.
73. Wiles, DH, Orr, MW, Kolakowska, T. (1978) Chlorpromazine levels in plasma and milk of nursing mothers. Br J Clin Pharmacol 5: 272-273.